K. Sridhar

发表

Specific Plasma Autoantibody Reactivity in Myelodysplastic Syndromes

George I. Mias, Yan Zhang, Rui Chen, 2013, Scientific Reports.

Treatment of higher risk myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910.Na.

D. Felsher, P. Greenberg, A. Fan, 2010, Leukemia research.

Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes

I. Weissman, S. Schrier, P. Greenberg, 2013, Proceedings of the National Academy of Sciences.

Heme Oxygenase-mediated Resistance to Oxygen Toxicity in Hamster Fibroblasts*

D. Spitz, P. Dennery, K. Sridhar, 1997, The Journal of Biological Chemistry.

Differences in basal and hyperoxia-associated HO expression in oxidant-resistant hamster fibroblasts.

D. Spitz, P. Dennery, H. E. Wong, 1996, The American journal of physiology.

Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression.

Robert Tibshirani, Atul J Butte, R. Tibshirani, 2009, Blood.

Differential Gene Expression Profiles in CD34+ Myelodysplastic Syndrome Marrow Cells.

R. Tibshirani, I. Weissman, P. Brown, 2005 .

Nanoscale approaches to define biologic signatures and measure proteomic response to targeted therapies in hematologic and solid tumors

Nancy R. Zhang, Y. Natkunam, D. Felsher, 2010 .

Abstract B178: Nanoscale quantification of phosphorylated and unphosphorylated ERK and MEK isoforms differentiates tumor and nontumor clinical specimens

Nancy R. Zhang, D. Felsher, R. Pai, 2009 .

Transcriptomic Evaluation of CD34+ Marrow Cells from Myelodysplastic Syndrome (MDS) Patients

Rui Chen, G. Mias, P. Greenberg, 2014 .

Reduced rRNA expression and increased rDNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes.

P. Greenberg, B. Mitchell, A. Raval, 2012, Blood.

MMP9 inhibition increases erythropoiesis in RPS14-deficient del(5q) MDS models through suppression of TGF-β pathways.

P. Greenberg, Shuo Lin, Haigen Huang, 2019, Blood advances.

Distinct transcriptomic and exomic abnormalities within myelodysplastic syndrome marrow cells

Rui Chen, M. Snyder, A. Graber, 2018, Leukemia & lymphoma.

Characterization of the Functional Interaction of Adipocyte Lipid-binding Protein with Hormone-sensitive Lipase*

S. Patel, D. Bernlohr, F. Kraemer, 2001, The Journal of Biological Chemistry.

Protective effects of transient HO-1 overexpression on susceptibility to oxygen toxicity in lung cells.

P. Dennery, T. Hansen, K. Sridhar, 1999, American journal of physiology. Lung cellular and molecular physiology.

Profiling myelodysplastic syndromes by mass cytometry demonstrates abnormal progenitor cell phenotype and differentiation

G. Nolan, R. Finck, P. Greenberg, 2019, bioRxiv.

In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial

M. Prisco, D. Keene, A. South, 2022, Nature Medicine.

Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.

M. Marinkovich, K. Sridhar, T. Parry, 2022, The New England journal of medicine.

Protective effects of transient HO-1 overexpression on susceptibility to oxygen toxicity in lung cells

P. Dennery, T. Hansen, K. Sridhar, 1999 .

Interaction of rat hormone-sensitive lipase with adipocyte lipid-binding protein.

D. Bernlohr, F. Kraemer, W. Shen, 1999, Proceedings of the National Academy of Sciences of the United States of America.

NPM1 Haploinsufficiency Results in Increased Numbers of Hematopoietic Stem Cells and Progenitor Cells.

I. Weissman, P. Greenberg, B. Mitchell, 2009 .